Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis

NCT01736397 is registered in ClinicalTrials.gov with Keryx Biopharmaceuticals as lead sponsor.

NCT NCT01736397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01736397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Lead sponsor
Keryx Biopharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2012
Completion date
December 31, 2013
Enrollment
149 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

iron deficiency, iron deficiency anemia